Bavarian Nordic A/S (OMX: BAVA) today announced that the Swiss Agency for Therapeutic Products, Swissmedic, has approved ...

Comirnaty (COVID-19 Vaccine, mRNA) mRNA COVID-19 vaccine (2025-2026 formulation targeting the LP.8.1 variant) For active immunization to prevent COVID-19 caused by SARS-CoV-2 in adults aged 65 years ...

The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®. The new vaccine is indicated for active immunization to prevent COVID-19 caused by SARS ...

The ACIP voted that Penmenvy may be used as part of the adolescent meningococcal vaccination schedule as an alternative to separate administration of MenACWY and MenB. The Centers for Disease Control ...

Explore the latest advances in RSV vaccine research, and what these developments mean for prevention and public health.